AHNTI EU has unveiled the finalists of its 2026 Innovation Showcase, spotlighting high-potential early-stage companies across animal health, nutrition and technology. The selected innovators will pitch live in London on 2 March 2026.
Innovation is reshaping the future of animal health, accelerating earlier diagnosis, improving welfare outcomes, advancing sustainability in food systems, and enabling new therapeutic and preventive solutions at scale. As global challenges continue to grow across companion animal care and livestock production alike, the need for breakthrough thinking and investable innovation has never been greater.
That is why AHNTI EU (Animal Health, Nutrition & Technology Innovation) has announced the 2026 Innovation Showcase Finalists — a curated group of early-stage companies identified as the “ones to watch” across Nutrition, Diagnostics, Biopharma, and Technology. These finalists will take to the stage 2 March 2026 in London at Convene St Paul’s, pitching live during AHNTI EU in front of an audience of 850+ industry leaders, investors, pharma, biotech, CDMOs, and strategic partners.
Selected by AHNTI’s prestigious selection committee of investors and industry leaders, the finalists represent some of the most exciting emerging solutions in the market, each demonstrating strong potential to transform the animal health ecosystem and create meaningful opportunities for partnership and investment.
Finalists to pitch live on 2 March 2026 at Convene St Paul’s, London.
| The 2026 AHNTI EU Innovation Showcase Finalists | |
| BIOPHARMA | TECHNOLOGY |
| BioAZ – Biotechnology company advancing animal health and welfare through high-impact scientific solutions. Modulant Bioscience – Small molecule therapeutics targeting multiprotein complexes involved in infectious and chronic disease. NanoVet Biotech – Camelid-derived nanobodies and biologics with programs spanning dermatology, cancer therapies, osteoarthritis, and kidney disease. Pasture Biosciences – Developing next-generation veterinary vaccines including a cattle vaccine aiming to improve feed efficiency and reduce methane emissions. | Athian – Carbon marketplace for livestock to aggregate, verify, and monetize on-farm greenhouse gas reductions. MariHealth Solutions – Bioinformatics and deep data analytics turning biological data into actionable insights for animal health and nutrition. Photon Therapeutics – Ophthalmic research and clinical science collaboration developing compliant, patient-focused solutions. Vet Vision AI – AI-driven machine vision and real-time monitoring for welfare, behaviour, and health insights to support earlier intervention. |
| NUTRITION | DIAGNOSTICS |
| Agteria Biotech – Developing a methane-reducing compound for cattle to help cut agricultural emissions while maintaining health and productivity. NanosVet – Needle-free medicine through dissolvable oral nanostrips, launching with an epi-pen equivalent for pets. Pet Diet Plans – Personalised diet plans and practical nutrition support for long-term pet wellness and quality of life. PhageLab – Bacteriophage-based solutions supporting alternatives to antibiotics and addressing antimicrobial resistance. | PrediPet – Simple blood test to detect, monitor, and screen for cancer and tumour-related disease in dogs. InsituGen – Patented bioassay technology measuring steroid hormone bioactivity for sensitive, non-targeted screening. Pictor – Multiplex proteomics and ELISA-based testing for human and animal health with faster turnaround and lower cost. PRONOVA – At-home saliva-based biosensor platform for dogs delivering biomarker insights in ~15 minutes via mobile app. |
LIVE PITCHING AT AHNTI EU — 2–4 MARCH 2026
The Innovation Showcase will take place during AHNTI EU in London, bringing together decision-makers across animal health, nutrition, biotech, pharma, investment, and corporate development for three days of partnering and high-impact programming. Finalists will pitch live to the AHNTI EU audience, with opportunities for strategic discussions and follow-on meetings throughout the event.
